The another side of COVID-19 in Alzheimer's disease patients: Drug-drug interactions

被引：11
作者：
Balli, Nisa [1 ]
Kara, Emre [1 ]
Demirkan, Kutay [1 ]
机构：
[1] Hacettepe Univ, Fac Pharm, Dept Clin Pharm, Ankara, Turkey
来源：
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE | 2020年 / 74卷 / 10期
关键词：
D O I：
10.1111/ijcp.13596
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 5 条
[1]   Clinically Relevant Drug Interactions with Anti-Alzheimer's Drugs [J].
Caraci, Filippo ;
Sultana, Janet ;
Drago, Filippo ;
Spina, Edoardo .
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2017, 16 (04) :501-513
[2]   Potential drug-drug interactions in Alzheimer patients with behavioral symptoms [J].
Pasqualetti, Giuseppe ;
Tognini, Sara ;
Calsolaro, Valeria ;
Polini, Antonio ;
Monzani, Fabio .
CLINICAL INTERVENTIONS IN AGING, 2015, 10 :1457-1466
[3]  
Pytliak M, 2011, DRUGS HYPOGLYCEMIA H, P131
[4]  
University of Liverpool, 2020, COVID 19 DRUG INT
[5]   Dementia care during COVID-19 [J].
Wang, Huali ;
Li, Tao ;
Barbarino, Paola ;
Gauthier, Serge ;
Brodaty, Henry ;
Molinuevo, Jose Luis ;
Xie, Hengge ;
Sun, Yongan ;
Yu, Enyan ;
Tang, Yanqing ;
Weidner, Wendy ;
Yu, Xin .
LANCET, 2020, 395 (10231) :1190-1191
1